---
schema_version: "secwatch.filing_event.v1"
accession: "0001522767-25-000222"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2025-11-05T23:59:59+00:00"
generated_at: "2026-05-17T00:15:50.129248+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MariMed Q3 revenue $40.8M, adjusted EBITDA $5.1M; expands brands to 3 new states

## Summary
- Revenue flat at $40.8M (Q3 2024: $40.6M); GAAP net loss widened to $2.9M from $1.0M.
- Adjusted EBITDA rose to $5.1M from $4.7M; margin improved to 13% from 12% YoY.
- Sequential growth in wholesale and retail; new brand distribution agreements in Maine, Pennsylvania, and New York.
- Delaware adult-use sales launched; Metropolis, IL location impacted by new competition.
- Nine-month revenue $118.2M vs $118.8M; GAAP net loss $9.8M vs $4.2M.

## SEC filing metadata
- accession: 0001522767-25-000222
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2025-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000152276725000222/0001522767-25-000222-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000152276725000222/mrmd-20251105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001522767-25-000222
- JSON: https://secwatch.observer/filing/0001522767-25-000222.json
- Plain text: https://secwatch.observer/filing/0001522767-25-000222.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.